A planned redesign of the European patent system, announced last week (December 4th), could reduce the cost and strengthen the legal weight of European patents -- a change that biotechnology companies have long awaited. Image: WikipediaCurrently, a European patent can cost companies up to 11 times as much as they would pay in the United States, while providing far fewer legal certainties. The existing patent system is simply a bundle of 4-6 national patents; applicants must choose the countries
 |
Image: Wikipedia |
A citizen science game explores how social choices and networks can influence how an illness moves through a population.
View this Issue
Learn how a next-generation platform accelerates biological research by enabling high-throughput, spatially resolved multiomics profiling.
In this webinar, Imogen Binnian will share how AI and gene synthesis technology can accelerate the discovery and validation of novel disease traits.
Real-time imaging enhances fluorescence activated cell sorting (FACS) to help scientists overcome the cost and burden of validation.
New innovations provide scientists with easy access to robust and accurate control samples for quality control applications.
Setting new standards for intelligent mass detection, sensitivity, and sustainability.
The Wellcome Sanger Institute, Helmholtz Munich, and Parse Biosciences have announced a landmark international collaboration to create a Cancer Plasticity Atlas.
Multi-center project will profile over 40,000 samples using ultra-sensitive NULISA™ technology.
Discover how Alderley Analytical meet regulatory demands and high-throughput challenges—processing 10,000+ dirty samples with consistent performance of the Xevo TQ Absolute XR Mass Spectrometer.
